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Pluripotent stem cell lines with similar phenotypes can be derived from both blastocysts (embryonic stem cells, ESC) and primordial germ cells
(embryonic germ cells, EGC). Here, we present a compendium DNA microarray analysis of multiple mouse ESCs and EGCs from different
genetic backgrounds (strains 129 and C57BL/6) cultured under standard conditions and in differentiation-promoting conditions by the withdrawal
of Leukemia Inhibitory Factor (LIF) or treatment with retinoic acid (RA). All pluripotent cell lines showed similar gene expression patterns, which
separated them clearly from other tissue stem cells with lower developmental potency. Differences between pluripotent lines derived from different
sources (ESC vs. EGC) were smaller than differences between lines derived from different mouse strains (129 vs. C57BL/6). Even in the
differentiation-promoting conditions, these pluripotent cells showed the same general trends of gene expression changes regardless of their origin
and genetic background. These data indicate that ESCs and EGCs are indistinguishable based on global gene expression patterns alone. On the
other hand, a detailed comparison between a group of ESC lines and a group of EGC lines identified 20 signature genes whose average expression
levels were consistently higher in ESC lines, and 84 signature genes whose average expression levels were consistently higher in EGC lines,
irrespective of mouse strains. Similar analysis identified 250 signature genes whose average expression levels were consistently higher in a group
of 129 cell lines, and 337 signature genes whose average expression levels were consistently higher in a group of C57BL/6 cell lines. Although
none of the genes was exclusively expressed in either ESCs versus EGCs or 129 versus C57BL/6, in combination these signature genes provide a
reliable separation and identification of each cell type. Differentiation-promoting conditions also revealed some minor differences between the cell
lines. For example, in the presence of RA, EGCs showed a lower expression of muscle- and cardiac-related genes and a higher expression of
gonad-related genes than ESCs. Taken together, the results provide a rich source of information about the similarities and differences between
ESCs and EGCs as well as 129 lines and C57BL/6 lines. Such information will be crucial to our understanding of pluripotent stem cells. The
results also underscore the importance of studying multiple cell lines from different strains when making comparisons based on gene expression
analysis.
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Embryonic stem cells (ESCs) and embryonic germ cells
(EGCs) are prototypical pluripotential stem cells cultured in
vitro. Mouse ESCs can be derived from the inner cell mass⁎ Corresponding author. Fax: +1 410 558 8331.
E-mail address: kom@mail.nih.gov (M.S.H. Ko).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.05.004(ICM) of blastocysts (Evans and Kaufman, 1981; Martin,
1981), whereas mouse EGCs can be derived from primordial
germ cells (Matsui et al., 1992; Resnick et al., 1992). Similar
cells have also been derived from human ICM (Thomson et al.,
1998) and PGCs (Shamblott et al., 1998), respectively. Both
ESCs and EGCs possess two defining characters of pluripotent
stem cells: self-renewal, i.e., ability to produce daughter cells
with an identical phenotype, and pluripotency, i.e., ability to
447L.V. Sharova et al. / Developmental Biology 307 (2007) 446–459give rise to most differentiated cell types, including germ cells
(Hadjantonakis and Papaioannou, 2001; Labosky et al., 1994;
Loebel et al., 2003; Smith, 2001; Stewart et al., 1994).
Furthermore, both ESC and EGC express the same pluripotency
markers, such as Pou5f1 (also known as Oct3/4, Oct3, Oct4),
Nanog, Zfp42 (also known as Rex1), and alkaline phosphatase
(ALP). Thus, ESCs and EGCs are often considered as
essentially equivalent cell types. Such similarity has recently
led to a hypothesis that ESCs are also derived from PGC
precursors that are originated from the ICM (Zwaka and
Thomson, 2005).
There are, however, some known differences between ESC
and EGC. For example, chimeras generated using some EGCs
derived from postmigratory PGC from the genital ridge had
fetal overgrowth and skeletal abnormalities (McLaren and
Durcova-Hills, 2001; Tada et al., 1998). It has been reported that
EGCs failed to differentiate in a co-culture with lung tissue,
whereas ESC successfully differentiated in these conditions
(Durcova-Hills et al., 2003). In vitro, EGCs differentiated more
efficiently to neuronal cells and less efficiently to cardiac and
skeletal muscle cells than ESC (Rohwedel et al., 1996). As far
as we know, there are no surface or other markers that can
distinguish between mouse ESC and EGC lines. The only
known molecular difference is the DNA methylation patterns of
some imprinted genes.
Another important difference between ESCs and EGCs is
related to how these pluripotent cells are derived. Pluripotent
ESCs are derived from pluripotent ICM of blastocysts, whereas
pluripotent EGCs are derived from unipotent (or sometimes
called nullipotent (Donovan and de Miguel, 2003)) PGCs,
which can differentiate only to sperm or oocytes. Therefore,
ICM cells converting to ESCs need to acquire only the capacity
to proliferate actively in culture for long periods without
differentiation (self-renewal), but PGCs converting to EGCs
need to acquire both self-renewal and pluripotency. Therefore,
the changes that occur during the conversion of PGCs to EGCs
are often compared to those seen after the transplantation of
nuclei from differentiated cells into enucleated oocytes
(“nuclear reprogramming”) (Donovan and de Miguel, 2003;
Hochedlinger and Jaenisch, 2006). Here, we ask whether these
seemingly different mechanisms involved in deriving ESCs and
EGCs are reflected in the molecular characteristics of the cells
in culture.
Although the mouse ESCs have been studied in great detail
by global gene expression profiling (e.g., Anisimov et al., 2002;
Brambrink et al., 2006; Furusawa et al., 2006; Ivanova et al.,
2002; Ramalho-Santos et al., 2002; Tanaka et al., 2002; Wei et
al., 2005), comparisons between ESC and EGC have been
limited to the analysis of EST frequency in one ESC line versus
one EGC line (Sharov et al., 2003). Therefore, the main
question still remains open of whether ESCs and EGCs are
distinct or equivalent cell types from the viewpoint of global
gene expression patterns. As a first step to address this question,
we have examined the global gene expression profiles of mouse
ESCs and EGCs. To avoid detecting cell line-specific gene
expression patterns, we examined multiple ESC lines and EGC
lines, which have been established independently. Consideringthat gene expression profiles might be affected by genetic
background, we tested cell lines derived from different mouse
strains. Finally, we examined possible differential responses of
ESC and EGC lines to differentiation-promoting stimuli,
namely the absence of LIF and the presence of retinoic acid
(RA).
Results
Phenotype and cell cycle analysis of pluripotent cell lines
We first examined the phenotypes of 6 mouse ESC lines and
10 mouse EGC lines (Table 1) cultured for 3 days in three
different conditions: with LIF (LIF+, the standard culture
condition), without LIF (LIF−, the differentiation-promoting
condition), and with LIF and RA (RA+, the differentiation-
promoting condition) (see the Materials and methods for
details). In the standard culture conditions, all cell lines
examined here showed similar morphology and growth (Fig.
1A). When these cells were cultured in the differentiation-
promoting conditions, we observed three early indicators of
differentiation: a decreased signal intensity of alkaline phos-
phatase (ALP) staining, the flattening of ESC and EGC
colonies, and the emergence of distinct single cells at the
edges of colonies. These early signs of differentiation were
noted by day 2 with RA and by day 3 in the absence of LIF (Fig.
1A). By day 3, most cells exposed to RA were already well-
differentiated, with a morphology resembling epithelial or
endodermal cells. However, at day 3, the cells cultured without
LIF did not show any obvious signs of differentiation into a
particular cell lineage, although the colonies already showed flat
morphology and low intensity or patchy ALP staining. In the
presence of RA, cells with a differentiated phenotype were
slightly more abundant in ESC lines than in EGC lines.
It is known that pluripotent cells have a unique cell cycle:
most cells are found in the S phase of the cell cycle and the G1
phase is short (Savatier et al., 1996). In the presence of LIF, all
cell lines examined here showed a distribution of 57.7%–66.3%
cells in S phase and 13.8%–23.4% cells in G1 phase (Fig. 1B),
as it has been reported for undifferentiated ESC (Savatier et al.,
1996). As expected, upon differentiation the proportion of cells
in the G1 phase of the cell cycle increased while the proportion
of cells in S phase decreased. However, these changes were
relatively small, probably because cells were not fully differen-
tiated after 3 days in the RA+ and LIF− conditions. The
proportion of cells in G1 phase of the cell cycle was lower in
EGC than in ESC (GLM, p=0.033), especially in the RA+
condition.
Global expression profiling of pluripotent cell lines
Using a whole-genome NIA 44K oligo-DNA microarray, we
obtained the global gene expression profiles of six mouse ESC
lines and six mouse EGC lines cultured for 3 days in LIF+, LIF−,
and RA+ conditions. To assess the expression profiles of these
cells in a larger context, we first compared them with our
previous microarray data obtained from trophoblast stem (TS)
Table 1
Pluripotent cell lines used in the study
Name of
cell line
Mouse
strain
Cell
type
Feeder
dependency
Sex Source Comments and reference
BL6.9 C57BL/6 ESC + M JHU aka MC2-B6
CC9.3.1 129SvEv-Gpi1c ESC + F Grant
MacGregor
(Sligh et al., 2000); developed by Allan Bradley
129.3 129SvEv-Tac ESC + M JHU aka MC1
ES-D3-GL 129/SV+c/+p ESC + M ATCC Catalog No SCRC-1003 (Doetschman et al., 1985)
EBRTcH3 129Ola ESC − M Hitoshi Niwa Derived from EB3 (E14tg2a), genetically modified (Masui et al., 2005)
MG1.19 129Ola ESC − M Hitoshi Niwa Derived from CCE, genetically modified (Camenisch et al., 1996)
TGC 8–5 a C57BL/6 EGC + M Brigid Hogan Derived from 8 dpc embryo; methylation of Igf2r region 2 (met/unmet, partial)
(Labosky et al., 1994)
TGC 8–7 C57BL/6 EGC + F Brigid Hogan Derived from 8 dpc embryo; methylation of Igf2r region 2 (unmet) (Labosky et al., 1994)
TGC 8–8 C57BL/6 EGC + M Brigid Hogan Derived from 8 dpc embryo; methylation of Igf2r region 2 (unmet) (Labosky et al., 1994)
TGC 8–9 a C57BL/6 EGC + M Brigid Hogan Derived from 8 dpc embryo; methylation of Igf2r region 2 (unmet) (Labosky et al., 1994)
TGC 8–12a C57BL/6 EGC + M Brigid Hogan Derived from 8 dpc embryo; methylation of Igf2r region 2 (met/unmet, somatic)
(Labosky et al., 1994)
TGC 8.5–5 C57BL/6 EGC + M Brigid Hogan Derived from 8.5 dpc embryo; methylation of Igf2r region 2 (met/unmet, partial)
(Labosky et al., 1994)
TGC 8.5–19a C57BL/6 EGC + M Brigid Hogan Derived from 8.5 dpc embryo; methylation of Igf2r region 2 (unmet); germ line
transmission (Labosky et al., 1994)
TGC 12-8 C57BL/6 EGC + M Brigid Hogan Derived from genital ridge of 12.5 dpc embryo; methylation of Igf2r region 2 (unmet)
(Labosky et al., 1994)
EG-1 129Sv EGC + M Colin Stewart Derived from 9 dpc embryo (Stewart et al., 1994)
EG-3 129Sv EGC + F Colin Stewart Derived from 9 dpc embryo (Stewart et al., 1994)
a Samples used for qRT-PCR only. All other samples were used for microarray analysis.
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Direct comparison was possible because both studies used the
same type of microarrays with a largely overlapping set
(N=20,088) of 60-mer oligos, and both studies included the
same ESC line 129.3, which was used as a common standard for
data normalization. Results of principal component analysis
(PCA) of log-transformed gene expression values showed that
the gene expression profiles of ESC and EGC lines were similar
to each other and were clearly separated as a single group from
those of TS and NSC (Fig. 2).
Although ESCs and EGCs were inseparable in the above
analysis, we wished to identify the differences among
individual cell lines. First, we applied ANOVA statistics to
the microarray data of all ESC and EGC lines in the standard
LIF+ condition and found that 6998 genes had a significant
difference in their expression among individual ESC and EGC
lines (Table S1). The PCA of these genes revealed considerable
variations among individual cell lines. We found that 129 cell
lines and C57BL/6 cell lines were best separated along a linear
combination of principal components 1 and 2 (PC1+
0.69·PC2), whereas ESCs and EGCs were separated along
the PC3 axis (Fig. 3). However, the cell lines-to-cell lines
variations within ESC and EGC groups were too large to draw
clear-cut boundary between these categories (Fig. 3). For
example, two EGC lines (TGC 8.5-5 and TGC 8-8) had gene
expression similar to the ESC line BL6.9, whereas other 4 EGC
lines had a more distinct gene expression pattern. In general,
the difference in gene expression patterns between ESCs and
EGCs was smaller than that between mouse strains because the
former was represented only by the 3rd principal component
(PC3), but the latter was represented by the first two principal
components (PC1 and PC2). Therefore, we conclude that ESCsand EGCs are not distinct entities in relation to global gene
expression.
We expected sex-specific differences of global gene
expression profiles in ESCs and EGCs. However, we did not
find any principal component that separated female cell lines
(CC9.3.1, TGC 8-7, and EG-3) from male lines. Three Y-linked
genes (Eif2s3y, Uty, and Ddx3y) were more highly expressed
(pb0.001) in male cell lines than in female cell lines, whereas
four X-linked genes (Xlr5d, Xlr5c, and 1700013H16Rik) were
more highly expressed (pb0.04, fold change N2) in female cell
lines. However, such a few sex-related genes did not satisfy the
stringent statistical criteria by the false discovery rates (FDR;
see Materials and methods for the detail). Pluripotent cell lines
have thus limited sex-related differences in gene expression. We
also expected stage-specific differences in the expression
profiles of EGCs. However, we did not detect any specific
gene expression patterns that correlated to the stage of EGC
source, e.g., pre-migratory PGC (8–8.5 dpc) or post-migratory
PGC (12 dpc) stages.
Variability of gene expressions among pluripotent cell lines
The separation of individual pluripotent cell lines by the
PCA reflects the differences in their global gene expression
patterns among the cell lines. To investigate what genes
contributed to these differences, we sought genes whose
expression levels changed significantly between cell lines
(FDR≤0.05, fold change N1.5) and correlated (abs(r)N0.7) to
those principal components that separated cell lines based on
their strain and origin (Fig. 3). We found four sets of genes
(Table S2–S3): 580 genes were correlated positively to PC1+
0.69·PC2 and thus were generally more highly expressed in 129
Fig. 1. Phenotypes of representative pluripotent cell lines cultured on gelatin-coated dishes in the standard LIF+ condition, LIF− condition, and RA+ condition for
3 days. (A) Morphologies of cells stained with alkaline phosphatase (ALP). (B) Cell cycle structures analyzed by the flow cytometry.
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genes were correlated negatively to PC1+0.69·PC2 and thus
were generally more highly expressed in C57BL/6 cells than in
129 cells (“C57BL/6-overexpressed genes”); 207 genes were
correlated positively to the PC3 and thus were generally more
highly expressed in EGC lines than ESC lines (“EGC-
overexpressed genes”); and 35 genes were correlated negatively
with PC3 and thus were more highly expressed in ESC lines
than EGC lines (“ESC-overexpressed genes”).First, we analyzed these four sets of genes from the
viewpoint of their pluripotency. Previously, we have shown
that NSCs and TS cells already commit to specific cell
lineages and express many genes that are characteristic of
differentiated cells (Aiba et al., 2006). From the PCA (Fig. 2),
we extracted 1719 genes that were negatively associated with
PC1, which represented genes expressed more highly in
pluripotent ESCs and EGCs than in the lineage-committed
NSCs and TS cells (Table S4). These candidate “pluripotency-
Fig. 2. Principal component analysis (PCA) of global gene expression patterns
in pluripotent cell lines (ESC and EGC), neural stem/progenitor cells (NSC), and
trophoblast stem (TS) cells. Cells were plotted according to their coordinates on
the principal component 1 (PC1) and the principal component 2 (PC2).
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Nr0b1 (Dax1), Tcl1, Dppa3 (Stella), Dppa4, Klf2, Klf4,
Jarid2, Jarid1b, and Foxd3 (Anisimov et al., 2002; Boyer et
al., 2005; Gordeeva et al., 2005; Hanna et al., 2002; Li et al.,
2005; Mongan et al., 2006; Niakan et al., 2006; Player et al.,
2006; Sharov et al., 2003; Yoshikawa et al., 2006). The
pluripotency-related genes were more abundant in the 129-Fig. 3. Principal component analysis (PCA) of global gene expression patterns in p
according to their coordinates on the PC1+0.69·PC2 and PC3. These principal comp
vs. 129) and origins (EGC vs. ESC). Error bars were determined with ANOVA. Maj
type are shown together with representative genes for transcription factors, growth
genes” (see the text for the definition) in sets of genes that were positively or negatoverexpressed gene list than the C57BL/6-overexpressed gene
list (chi-square=19.4; pb0.001) (Fig. 3), but there was no
significant difference in the proportion of pluripotency-related
genes in EGC- and ESC-overexpressed gene lists (chi-
squareb0.001; p=1). These data suggest that ESC and EGC
show no difference in the degree of pluripotency, whereas
C57BL/6 lines have a greater tendency to lose their pluripo-
tency than 129 cell lines, at least after 3 days in culture in the
standard LIF+ condition. Genes that were differentially
expressed between strains did not include the canonical
pluripotency genes (Pou5f1, Nanog, and Sox2); however, the
expression level of Zfp42, which was already high in C57BL/6
lines, was much higher in 129 cell lines (Table S2, Fig. 5B).
Second, we analyzed these four sets of genes based on gene
ontology (GO) terms (Fig. 3; see Tables S5–S7 for the details).
The 129-overexpressed genes were classified as being asso-
ciated with cytokine production, amino acid metabolism, lipid
transport, and actin cytoskeleton. Higher cytokine production
may be related to the fact that 129-derived cell lines have faster
proliferation rate than C57BL/6-derived cell lines in the
standard LIF+ culture condition (data not shown). They also
included many genes with unknown functions. The C57BL/6-
overexpressed genes were classified as being associated with
oxidoreductase activity, steroid metabolism, lysosome, spliceo-
some, protein transport, apoptosis, ubiquitination activity, and
GTPase activity. Because the number of ESC-overexpressed
genes was very limited (N=35), there were no statisticallyluripotent cell lines in the standard LIF+ culture condition. Cells were plotted
onents (PCs) best separated pluripotent cells according to their strains (C57BL/6
or gene ontology (GO) categories of genes that were overexpressed in each cell
factors, and hormones. Pie charts show the proportion of “pluripotency-related
ively correlated with each PC.
Fig. 4. Average expression levels of signature genes can separate pluripotent
cells in the standard LIF+ culture condition according to their origins and strains.
(A) Cells were plotted according to the average log-transformed expression
levels of 20 ESC signature genes and 84 EGC signature genes. (B) Cells were
plotted according to the average log-transformed expression levels of 100 129
signature genes and 100 C57BL/6 signature genes.
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associated with tRNA aminoacylation, cytokinesis, translation,
and ubiquitination activity. It is worth mentioning that genes
involved in methyltransferase activity (Mettl5, Smyd3, Dnmt3l)
were overexpressed in the EGCs, which may indicate that the
status of chromatin modifications in EGCs is different from that
in ESCs.
Signature genes that distinguish strains and origins of
pluripotent cells
One of our original goals was to identify marker genes that
can separate ESCs and EGCs. The comparison between a single
ESC line and a single EGC line revealed many such
differentially expressed genes. However, subsequent analysis
showed that these genes were merely cell line-specific and did
not show consistent differential expression between multiple
ESCs and multiple EGCs (e.g., Supplemental Fig. S1).
To find signature genes that are most consistently different
between ESC and EGC lines in all culture conditions, we
grouped the cells according to their origin (e.g., ESC vs. EGC)
and carried out the statistical analysis (ANOVA) between these
groups (see Materials and methods for the detail). We found 104
signature genes (20 genes for ESC and 84 genes for EGC),
whose average expression levels can distinguish each group
(Tables S8–S9). Although we did not find any gene that was
exclusively expressed in ESC or EGC, these groups were
separated by the average expression levels of signature genes
from each set (Fig. 4A), except one replication for cell line TGC
8-7. The top genes from signature lists were chosen for qRT-
PCR verification: 2 ESC-overexpressed genes (Grb10, Id2) and
3 EGC-overexpressed genes (Peg3, Spp1, Snrpn). qRT-PCR
results confirmed microarray data with all genes showing
differential expression across all tested 6 ESC and 10 EGC lines
(Fig. 5A). Out of 20 ESC signature genes, two (Id1 and Id2) are
known to be directly activated by Bmp4 (Hollnagel et al., 1999),
which may suggest that Bmp4 signaling is suppressed in EGC
lines. Among EGC signature genes some are associated with
extracellular matrix (Col16a1, Col1a1, Col8a1, Ecm1, Mfge8,
Postn, Serpinf1, Serpinh1, Slit2, Spp1, Timp1), which may be
related to the migratory pathway of parental PGC cells (Pereda
et al., 2006).
We also found 250 signature genes for cells derived from the
129 strain and 337 signature genes for cells derived from the
C57BL/6 strain in all three culture conditions (Tables S10–S11).
Cell lines derived from these different strains were well
separated by the average expression levels of top 100 signature
genes from each set (Fig. 4B). Differential expression of 7
signature genes Prdx2, Bhlhb2, Zadh2, Inpp5d, Tcstv3, Spink3,
and Zfp42 was confirmed using qRT-PCR (Fig. 5B). To test if
these differences were related to the degree of cell differentia-
tion, we compared the sets of signature genes with a set of 514
genes whose expressions were induced in ESCs and EGCs in the
LIF− condition (Table S12). In the set of 514 genes, more
C57BL/6 signature genes were represented than 129 signature
genes (16.6%, N=56 in the strain C57BL/6 versus 4.0%, N=10
in the strain 129; chi-square=22.9, pb0.001, see Tables S10,S11), indicating that cell lines derived from the C57BL/6 strain
had a higher tendency to differentiate than cell lines from the 129
strain. However, the majority of strain-specific signature genes
were not related to cell differentiation.
We found a few interesting examples that strain-specific
phenotypes of mice may be reflected in the strain-specific
signature genes. First, oxidoreductase activity was the top GO
category for C57BL/6-overexpressed genes (Fig. 3), 17 of
which were represented in the signature genes (e.g., Prdx2,
Dhrs7, Zadh2, Egln3, Mod1, Nxn, Phgdh, Gsr). This seems to
be consistent with the report that C57BL/6 mice have higher
resistance to oxidative stress and have a longer life span than
other strains (Rebrin and Sohal, 2004; Wesselkamper et al.,
2000; Zraika et al., 2006). Second, we noticed genes involved in
alcohol metabolism (Pkm2, Sgpp1, Slc37a4, Soat1, Vldlr,
Zadh2) in the C57BL/6 signature genes, which may be related
Fig. 5. Expression levels of selected genes measured by qRT-PCR. All 16 ESC
and EGC cell lines were used to validate the microarray data obtained from the
12 subset lines. (A) Average expression levels of 6 selected genes in ESC and
EGC cell lines in the standard LIF+ culture condition. The expression levels in
EGC cell lines were normalized by those in ESC cell lines and represented as
relative expression levels (fold difference). (B) Average expression levels of 10
selected genes in the cell lines derived from C57BL/6 and 129 mouse strains in
the standard LIF+ culture condition. The expression levels in C57BL/6-derived
lines were normalized by those in 129-derived lines and represented as relative
expression levels (fold difference). (C) Average expression levels of 8 selected
genes in ESC and EGC cell lines in the RA+ culture condition. The expression
levels in EGC cell lines were normalized by those in ESC cell lines and
represented as relative expression levels (fold difference).
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mice (Kelai et al., 2006). Third, we found that apoptosis-related
genes (Card4/Nod1 and Pmaip1) were at the top of the list in
the signature genes for strain C57BL/6, followed by additional
genes (Atm, Cebpb, and Dap). Indeed, the higher incidence of
apoptosis in C57BL/6 strain has been reported during oocyte
atresia (Canning et al., 2003) and ES cell differentiation (Ward
et al., 2004).
Frequent testicular cancer is a well-known phenotype of the
129 mouse strain (Matin and Nadeau, 2005). Dnd1 has recently
been identified as a gene responsible for Ter mutation, which is
the most potent testicular cancer modifier gene (Youngren et al.,
2005). We therefore examined whether the strain-specific
signature genes were cancer-related (based on PubMed andNCI/Biomax Cancer Gene Database, http://ncicb.nci.nih.gov/
NCICB/projects/cgdcp) and expressed in testis (based on EST
Profile Viewer (Larsson et al., 2000) in UniGene database). We
found that 6 such genes were overexpressed in the strain 129
(Anxa4, Dmd, Eno1, Gbp1, Gpr56, Tlr2); however, all of them
were tumor suppressors, and therefore, their high expression is
unlikely to cause cancer. In contrast, we found that 16 such
genes were under-expressed in the strain 129 (i.e., signature
genes for C57BL/6), 7 of which were either tumor suppressors
or negatively correlated with cancer (Atm, Dok2, Hdac1,
Herpud1, Pik3cd, Prdx2, Sfrp1). A list of genes identified
here may provide additional candidates for testicular cancer
modifier genes in the 129 strain.
Differential expression of imprinted genes in ESCs and EGCs
Previous study has shown the differential DNA methylation
of some imprinted genes between ESCs and EGCs (Durcova-
Hills et al., 2001; Labosky et al., 1994; Tada et al., 1998). Out of
60 mammalian imprinted genes reported so far (Luedi et al.,
2005), 6 genes (H19, Kcnq1, Nnat, Peg3, Snrpn, and U2af1-
rs1) were more highly expressed in EGCs, whereas 2 genes
(Calcr, Grb10) were more highly expressed in ESCs in the
standard LIF+ culture condition (Table 2). Grb10, a growth
suppressor (Smith et al., 2006), was also the top ESC signature
gene and Snrpn, U2af1-rs1, and H19 were among the top EGC
signature genes (Tables S8–S9). Differential expression of
Grb10, Peg3, and Snrpn was tested and confirmed by qRT-PCR
(Fig. 5A). Five genes out of seven imprinted genes that were
overexpressed in EGCwere mapped to chromosome 7 (Table 2).
Interestingly, 8 imprinted genes showed significant (pb0.05 and
N1.5-fold change) differences in expressions between mouse
strains at least in one of the differentiation-promoting conditions
(Table 2). For example, Peg3 and Dcn were more highly
expressed in the C57BL/6 strain, whereas Impact and Zfp264
were more highly expressed in the 129 strain.
Responses of pluripotent cells to differentiation-promoting
culture conditions: global trends
Although ESCs and EGCs were not separable by global gene
expression patterns in the standard culture condition, we
suspected that they might show more discernible differences
when induced to differentiate. To test this idea, we carried out the
expression profiling of ESC lines and EGC lines cultured for 3
days in LIF− and RA+ conditions. The PCA of the centered gene
expression profiles (see Materials and methods for the detail)
clearly showed that both ESCs and EGCs responded in a similar
manner to LIF withdrawal and RA treatments (Fig. 6). The first
major component PC1 corresponded to the changes associated
with the RA+ condition, whereas the second major component
PC2 corresponded to the changes associated with the LIF−
condition (Fig. 6). The data indicate that the RA+ condition
caused more dramatic change of global gene expression patterns
than the LIF− condition. In fact, the RA treatment caused a
qualitatively different and much stronger response in gene
expression (2613 genes with N1.5-fold change) than the LIF−
Table 2
Imprinted genes differentially expressed in pluripotent cell linesh a
Symbol Annotatin Maternal/
paternal
Chr Enriched Log ratio difference p-value b
LIF+ LIF− RA LIF+ LIF− RA
Grb10 c Growth factor receptor bound protein 10 Maternal 11a2 ESC −0.476 −0.498 −1.012 0.000 0.000 0.000
Calcr Calcitonin receptor Maternal 6a1 ESC −0.297 −0.334 −0.217 0.000 0.027 0.003
Ins1 Insulin I Paternal 19d2 ESC −0.038 −0.103 −0.205 0.144 0.008 0.000
Igf2r Insulin-like growth factor 2 receptor Maternal 17a2 ESC 0.067 −0.027 −0.376 0.053 0.599 0.000
Slc38a4 Solute carrier family 38, member 4 Paternal 15f2 ESC 0.040 −0.095 −0.210 0.321 0.089 0.000
Pon3 Paraoxonase 3 Maternal 6a1 ESC −0.029 −0.017 −0.200 0.332 0.821 0.001
Snrpn Small nuclear ribonucleoprotein N Paternal 7b5 EGC 0.292 0.356 0.535 0.000 0.000 0.000
U2af1-rs1 U2 small nuclear ribonucleoprotein auxiliary factor
(U2AF) 1, related sequence 1
Paternal 11a3 EGC 0.217 0.272 0.218 0.000 0.000 0.000
Nnat Neuronatin Paternal 2h2 EGC 0.240 0.203 0.283 0.001 0.042 0.025
Kcnq1 Potassium voltage-gated channel, subfamily Q, member 1 Maternal 7f5 EGC 0.117 0.206 0.183 0.010 0.006 0.031
H19 H19 fetal liver mRNA Maternal 7f5 EGC 0.241 0.224 0.412 0.000 0.165 0.035
Peg3 Paternally expressed 3 Paternal 7a1 EGC 0.287 0.157 0.116 0.000 0.112 0.008
Ascl2 Achaete–scute complex homolog-like 2 (Drosophila) Maternal 7f5 EGC 0.061 0.170 0.261 0.267 0.065 0.030
Peg3 Paternally expressed 3 Paternal 7a1 C57BL/6 −0.375 −0.214 −0.103 0.000 0.016 0.033
Dcn Decorin Maternal 10c3 C57BL/6 −0.139 −0.193 −0.105 0.005 0.006 0.391
Asb4 Ankyrin repeat and SC Maternal 6a1 C57BL/6 −0.257 −0.198 −0.120 0.000 0.226 0.329
Impact Imprinted and ancient Paternal 18a2 12 0.285 0.299 0.267 0.000 0.011 0.035
Zfp264 Zinc finger protein 264 Paternal 7a1 129 0.175 0.094 0.296 0.000 0.084 0.000
Calcr Calcitonin receptor delta-like 1 homolog Maternal 6a1 129 0.085 0.374 0.159 0.341 0.010 0.071
Dlk1 (Drosophila) Paternal 12f2 129 0.021 0.116 0.228 0.668 0.142 0.015
Gtl2 GTL2, imprinted maternally expressed untranslated mRNA Maternal 12f2 129 0.332 0.262 0.268 0.022 0.323 0.266
a Genes were differentially expressed (pb0.05 and N1.5 fold change) at least in one culture condition.
b Bold face of p-value indicates a significant difference in expression (pb0.05).
c Bold face of a gene symbol indicates significant differences (pb0.05) in all culture conditions.
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with the phenotypical differences observed between the RA+
and LIF− conditions (Fig. 1A): The RA+ condition induced
more active and faster differentiation than the LIF− condition. In
fact, the expressions of some pluripotency-related genes (e.g.,
Pou5f1, Sox2, Nanog, Aire, Otx2, Foxd3, and Tcea3) were
more sharply reduced in the RA+ condition than the LIF−
condition. The addition of RA to the basal conditions directedFig. 6. Principal component analysis (PCA) of global gene expression patterns
of pluripotent cell lines in the standard LIF+, LIF−, and RA+ conditions. Gene
expression levels were centered by subtracting cell line-specific average for all
culture conditions. Cells were plotted according to their coordinates on the PC1
and PC2.cells to a wide variety of lineages (neural, epithelial, endoderm,
and mesoderm) with a bias towards neural differentiation. For
example, genes induced selectively by RA included homeobox
genes (e.g., Esx1, Meis1, Hoxa1, Hoxa7, Hoxb1, Hoxa5,
Hoxa2, Hoxc9, Hoxa10, Hoxb7, Hoxb8) and genes involved in
morphogenesis (e.g., Tbx3), actin cytoskeleton, cell adhesion,
cell migration, extracellular matrix, and various types of
differentiation (e.g., neural, muscular, vascular, kidney, and
endodermal cells). The most highly induced genes were related
to neural differentiation (Pmp22, Mrg1, and Hoxa1). Genes
induced selectively by LIF withdrawal included fibroblast
growth factors (Fgf5, Fgf8, and Fgf15) and transcription factors
(T, Eomes, Lmyc1/Mycl1, Sp8, Irf1, Gsc, and Sp5) (Table S12),
many of which are mesoderm markers (T, Eomes, Fgf8, Fgf15)
(Loebel et al., 2003). Some pluripotency-related genes were
suppressed preferentially in the LIF− condition (Spp1, Klf4,
Esgp/EG653016, Piwil2, Kit), whereas other pluripotency-
related genes decreased both in the LIF− and RA+ conditions
(Nr0b1, Tcl1, Zfp459, Sall1, Gli1, Rest, Nr5a2, Lrrc2, Klf2,
Klf5, Klf9).
Responses of pluripotent cells to differentiation-promoting
culture conditions: origin- and strain-specific variations
Differentiation-promoting culture conditions generally reduced
the differences in gene expression levels among pluripotent cell
lines. For example, most ESC and EGC signature genes
identified in the standard LIF+ culture condition did not show
significant differences in their expression in the LIF− and RA+
conditions. Only 2 (10%) ESC signature genes (Grb10 and
454 L.V. Sharova et al. / Developmental Biology 307 (2007) 446–459Glo1) and 15 (18%) EGC signature genes (Atf5, Ccng2, Itpr3,
Mylpf, Pgm2, Pink1, Ralgds, Snf1lk, Snrpn, Snx6, Spp1,
Tbc1d13, Tmem40, Trib3, U2af1-rs1) showed persistentFig. 7. Expression levels of a set of genes that selected for the differential expression
culture condition. Gene expression levels were centered by subtracting cell line-spec
expressions in green and high expressions in red).differential expressions in all three culture conditions (Tables
S8–S9), indicating that these genes are the most reliable
separator between ESCs and EGCs. Similarly, many C57BL/6s between 129 and C57BL/6 (A) or between ESC and EGC (B) only in the RA+
ific average for all culture conditions and were represented in the heatmap (low
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in expression in the LIF− and RA+ conditions. For example,
Fgf5 showed a high expression in C57BL/6 lines and a low
expression in 129 lines in the standard LIF+ culture condition,
but its expression became equally high in all cell lines in the
LIF− condition and equally low in all cell lines in the RA+
condition. However, a higher proportion of strain-specific
signature genes retained their expression differences in the
differentiation-promoting conditions: 75 genes (30%) for 129
signature genes and 91 genes (27%) for C57BL/6 signature
genes (Tables S10–S11).
To further investigate the origin- and strain-specific varia-
tions in responses to differentiation-promoting culture condi-
tions, we focused on a set of genes that were differentially
expressed between 129 and C57BL/6 (Fig. 7A) or between ESC
and EGC (Fig. 7B), only after RA induced differentiation.
Genes that were overexpressed in the 129 cell lines after RA
treatment were associated with immune response (Lgals4,
H2-Bl, Ly6h, Cxcl10, Ccl3, H2-Q1, H2-Q5, H2-M10.2), muscle
differentiation (Myocd, Myl7), and cell cycle control (Gas1,
Fos) (Fig. 7A). In contrast, genes that were overexpressed in
the C57BL/6 cell lines in response to RA were associated with
secretion (Saa3, Saa1), the inhibition of Wnt signaling (Nkd1),
and the extracellular matrix (Col2a1, Mmp9).
Genes that were overexpressed in ESCs compared with EGCs
in the RA+ condition included the following functional groups:
(i) muscle development and actin cytoskeleton (Myocd, Acta1,
Myl7, Cgnl1, Flnb, Myl6, Tagln2, and Cald1), (ii) regulation of
transcription (Creb3l3, Foxd1, Hipk3, Rarb, Setbp1, Meis1,
and Bach2), and (iii) cell junction structure (Cgnl1, Flnb, Shrm/
Shroom3) (Fig. 7B). These results indicate that genes activated
in ESC lines by the RA treatment are more related to muscle
differentiation than those activated in EGC lines. Genes that
were selectively activated in EGCs compared with ESCs in the
RA+ condition are known to be expressed in ovary (Obox6,
Hoxc9, Mmp9, Saa1), blood (Hoxa9), and intestine (Cdx1).
Obox6 is expressed uniquely in oocytes (Rajkovic et al., 2002),
and Hoxc9 and Mmp9 are expressed in granulosa cells in the
ovary (Huntriss et al., 2006; Ke et al., 2004). qRT-PCR analyses
confirmed the overexpression ofMyocd,Myl7, and Plat in ESC
and Obox6 in EGC in the RA+ condition (Fig. 5C). These data
thus indicate that RA induced some gonad-related genes more
highly in the EGC lines than the ESC lines.
Discussion
We have compared the gene expression profiles of pluri-
potent stem cell lines with different genetic backgrounds and
derived from cells at different stages of development: the ICM
of blastocyst (ESC) and primordial germ cells (EGC). In
addition to the standard LIF+ culture conditions, we tested gene
expression after LIF withdrawal and RA treatment. As far as we
know, this is the first large-scale gene expression study of
various types of pluripotent stem cell lines. This data set (Table
S13) will thus be a valuable resource to the research community.
One of the main questions we wanted to address in this work
was whether ESCs and EGCs can be distinguished based onglobal gene expression patterns. Both ESC and EGC are
pluripotent stem cells and can differentiate into essentially all
the cell types in vivo and in vitro. Therefore, it has been an
important question whether the different origins of these cells
indeed cause any differences in their phenotypes and gene
expression regulation (Donovan and de Miguel, 2003; Durcova-
Hills et al., 2003; Hochedlinger and Jaenisch, 2006; Rossant,
1993). Here, we have shown many similarities and differences
between ESCs and EGCs as well as between C57BL/6 lines and
129 lines. From the perspective of global gene expression
profiles, we have shown in this paper that ESCs and EGCs are
indistinguishable. First of all, when the expression profiles of
multiple ESCs and EGCs were compared with those of NSC
and TS cells, all ESCs and EGCs were clustered as one group.
Second, even when comparing only ESCs and EGCs, variations
between individual cell lines were too great to clearly separate
them into two distinct groups, and the differences between
ESCs and EGCs were smaller than those between cells derived
from different strains. Differences of global gene expression
patterns measured by the PCA between one ESC line to another
ESC line were larger than those between one ESC line and EGC
line. It is important to point out that if we compared the global
expression profiles of only a few cell lines, we would have
erroneously concluded that ESC and EGC are separate entities
and identified marker genes specifically expressed in either ESC
or EGC.
Although we expected that our study would reveal
differences between ESCs and EGCs when they were induced
to differentiate, we failed to find such an effect in global gene
expression patterns. In both ESCs and EGCs, the RA treatment
caused a much stronger response in gene expression than the
LIF withdrawal. This is consistent with the phenotypical
differences observed between RA+ and LIF− conditions. The
addition of RA affected the expression of genes involved in a
wide variety of lineages (neural, epithelial, endoderm, and
mesoderm) with a bias towards neural differentiation, whereas
upon LIF withdrawal changes were biased towards mesoderm
lineage.
Considering possible differences between the nuclear
reprogramming process of ICM cells converting to ESCs and
that of PGCs converting to EGCs, the remarkable similarity of
gene expression patterns between ESCs and EGCs was
unexpected. The work presented here suggests that these
reprogramming events occur to the level where the global
gene expression patterns of EGCs are inseparable from those of
ESCs. Alternatively, this similarity between ESCs and EGCs
may simply support the hypothesis that ESCs are also derived
from PGC precursors that are originated from the ICM (Zwaka
and Thomson, 2005).
Although large variations of gene expression profiles
between cell lines within each category (e.g., ESCs) make it
difficult to separate pluripotent cells to distinct groups as
discussed above, it is possible to identify signature genes by
first grouping the cells according to their categories and then by
carrying out the statistical analysis to identify genes differen-
tially expressed between groups. Using this approach, we
identified 84 EGC signature genes and 20 ESC signature genes,
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between EGC and ESC lines, irrespective of mouse strains.
Although none of these genes was exclusively expressed in
either EGCs or ESCs, in combination they provide a reasonable
separation between these two cell types. These signature genes
included several imprinted genes: Grb10 was overexpressed in
ESC lines and Snrpn, U2af1-rs1, H19, and Nnat were
overexpressed in EGC lines. In total, 13 imprinted genes were
differentially expressed between ESC and EGC at least in one
culture condition. Imprinted genes are thus one of the few
features that reflect the origin of the pluripotent cell lines.
However, imprinted genes constitute only a minor portion
(∼5%) of ESC and EGC signature genes and cannot account for
the majority of differences between ESCs and EGCs. Although
EGC signature genes identified in the standard LIF+ culture
condition did not include germ line-specific genes, some ovary-
related genes were upregulated in these cells in the RA+
condition. The level of induction of genes related to muscular
differentiation was lower in EGCs compared with ESCs. As a
result, EGCs might be a more suitable starting material for
generation of germ cells in culture and would be a poor choice
in muscle development experiments. The most significant
differences in induction of differentiation-related genes between
EGC and ESC were observed for muscle-related genes in the
RA+ condition (Figs. 5C and 7A). It was reported previously
that mouse EGC line (EG-1) undergoing differentiation in the
embryoid body (EB) system has a limited ability to differentiate
into muscle and cardiac lineages (Rohwedel et al., 1996). In
addition, the proportion of cells in G1 phase of the cell cycle in
EGC was lower than in ESC in the RA+ condition. These
findings might indicate that EGCs were less differentiated in
the RA+ condition than ESCs, which could be caused by
either delayed response or lower sensitivity to differentiation
stimuli.
Using similar approaches, we have also identified a set of
genes that can distinguish C57BL/6 and 129 cells by their
average expression levels. One notable difference between
C57BL/6 cells and 129 cells is their relative pluripotency status
at day 3 of culture in the standard LIF+ condition. Cell lines
derived from C57BL/6 strain have their gene expression already
shifted towards more differentiated state, although they still
have a high expression of canonical pluripotency markers
(Pou5f1, Nanog, Sox2) and maintain normal ESC-like pheno-
type (Fig. 1) and normal ESC-like cell cycle (Fig. 2).
Interestingly, Zfp42, which is a well-known marker for
pluripotent cells, belongs to 129 signature genes. Although
Zfp42 was expressed at relatively high level in C57BL/6 cell
lines in the standard LIF+ condition compared to tissue-specific
stem cells, its expression was up to 10 times higher in 129 cell
lines than in C57BL/6 cell lines. We also noticed that the
C57BL/6 cells tended to show the slight reduction of ALP
staining level and the slight flattening of the cell colonies at the
day 3 in the standard LIF+ condition, compared with 129 cells
(data not shown). This earlier shift towards differentiation may
reflect cell's ability to respond to differentiating stimuli.
However, this shift to differentiation is only a minor aspect of
differences in gene expression between C57BL/6 and 129strains because the majority of strain-specific signature genes
were not related to cell differentiation.
It is known that it is easier to derive ES cell lines from the
129 strain than most other mouse strains (Ledermann, 2000).
ESCs derived from C57BL/6 are also known to have restricted
differentiation ability in some conditions: for example in the
medium without LIF and supplemented with RA they fail to
differentiate in neurons and die within 2 weeks in culture (Ward
et al., 2004). Their reported inclination to apoptosis matches
well with our analysis (Fig. 3). They are also less efficient in
producing chimeras and germ line transmission (Ward et al.,
2004), although for practical applications higher breeding
efficiency of the C57BL/6 strain seems to compensate these
drawbacks (Seong et al., 2004). We have shown in this report
that pluripotency-related genes are overexpressed in 129-
derived cells compared with C57BL/6-derived cells, which
might correlate with observations that 129-derived ES cells
produce chimeras with high percentage of germ line transmis-
sion. We also found candidate genes that may be responsible for
the difference in phenotypes between mouse strains. In
particular we found genes that are likely to be associated with
high resistance to oxidative stress, alcohol-preferring behavior,
and high level of apoptosis in C57BL/6 mice as well as genes
potentially associated with high prevalence of testicular cancer
in the 129 strain.
The current study has examined multiple ESCs and EGCs,
but the scope is still limited only to the subsets of all available
ESCs and EGCs. It will be thus interesting to extend the study to
other ESC and EGC lines. Moreover, it will also be interesting
to examine other reported pluripotent stem cells such as
multipotent adult progenitor cells (MAPCs; Jiang et al., 2002),
germline stem cells (GSCs; Kanatsu-Shinohara et al., 2004),
and multipotent adult germline stem cells (mpGSCs; Guan et
al., 2006) on the same platform to compare with the current data
sets. The ESC and EGC signature genes that we have identified
in this work may have a practical use to distinguish between
ESCs and EGCs as well as between 129 cells and C57BL/6
cells. Future studies on genes differentially expressed between
129 and C57BL/6 cells may also help to improve the germline
transmission efficiency of C57BL/6 ES cells in mouse gene
targeting strategy.Materials and methods
Cell culture
We used 6 mouse ESC lines, including 1 line derived from strain C57BL/6
and 5 lines derived from strain 129, and 10 mouse EGC lines, including 8 TGC
lines from strain C57BL/6 (established in the laboratory of B.L.M.H.) and 2 EG
lines from strain 129 (established in the laboratory of C.L.S.) (Table 1). BL6.9
(aka MC2-B6) and 129.3 (aka MC1) ESC lines were purchased from The
Transgenic Core Laboratory of the Johns Hopkins University School of
Medicine (Baltimore, MD, USA). ES-D3-GL ESC line was purchased from the
American Type Culture Collection (ATCC, Manassas, VA, USA). CC9.3.1 ESC
line, which was originally generated by Dr. Allan Bradley, was a kind gift of Dr.
Grant R. MacGregor (University of California, Irvine, CA, USA). EBRTcH3
and MG1.19 ESC lines were kind gifts of Dr. Hitoshi Niwa (RIKEN Center for
Developmental Biology, Kobe, Japan). Three cell lines were female and the
others were male; two ESC lines (EBRTcH3 and MG1.19) were genetically
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passages on gelatin-coated plates in the presence of Leukemia Inhibitory Factor
(LIF) in order to remove feeder cells. Cells were then transferred to gelatin-
coated 6-well plates at the density of 1–2×105 cells/well (1–2×104 cells/cm2)
and cultured for 3 days in 3 different conditions: (1) complete ES medium:
DMEM, 15% FBS; LIF (ESGRO, Chemicon, USA) 1000 U/ml; 1 mM sodium
pyruvate; 0.1 mM NEAA, 2 mM glutamate, 0.1 mM beta-mercaptoethanol, and
penicillin/streptomycin (50 U/50 μg per ml) (referred as “standard LIF+
condition”); (2) complete medium without LIF (referred as “LIF− condition”),
and (3) complete medium with 1 μM RA (referred as “RA+ condition”). Cells
were cultured at 37 °C and 5% CO2 condition and the culture medium was
changed daily. Undifferentiated state of pluripotent cells was confirmed by ALP
staining using Stem Cell Characterization kit (Chemicon, USA).
Cell cycle analysis
For cell cycle analysis, cells were plated on gelatin-coated 6-well plates at
the density of 1×104 cells/cm2 (105 cells/well). Cells were harvested at day 3,
washed in PBS, fixed in 70% ethanol, treated with RNase A (1 mg/ml final
concentration), and stained with propidium iodide (PI, Roche, 50 μg/ml final
concentration). Cell cycle analysis was performed using FACScan. Cell cycle fit
software (MacCycle-Phoenix Flow Systems) was used to estimate the
percentages of cells in various stages of the cell cycle.
Microarray experiments
For microarray experiments we used all 6 ESC cell lines and 6 EGC lines in
3 culture conditions (LIF+, LIF−, and RA+) (see Table 1 for the list of cell lines).
Experiments in the standard LIF+ condition were carried out with 2 to 3
biological replications, and experiments in the LIF− and RA+ conditions were
done without replications. At the day 3, Trizol™ (1 ml/well; Invitrogen, USA)
was added to the well and total RNAs were extracted using Phase lock gel™
columns (Eppendorf/Brinkman) according to the manufacturer's protocol. Total
RNAs were precipitated with isopropanol, washed with 70% ethanol, and
dissolved in DEPC-treated H2O. 2.5 μg of total RNA samples was labeled with
Cy3-CTP using a Low RNA Input Fluorescent Linear Amplification Kit
(Agilent, USA). A reference target (Cy5-CTP-labeled) was prepared from the
Universal Mouse Reference RNA (Stratagene, USA). Labeled targets were
purified using an RNeasy Mini Kit (Qiagen, USA) according to the Agilent's
protocol, quantitated by a NanoDrop scanning spectrophotometer (NanoDrop
Technologies, USA), and hybridized to the NIA Mouse 44K Microarray v2.2
(whole-genome 60-mer oligo; manufactured by Agilent Technologies, #014117)
(Carter et al., 2005) according to the Agilent protocol (G4140-90030; Agilent
60-mer oligo microarray processing protocol-SSC Wash, v1.0). All hybridiza-
tions were carried out in the two-color protocol by combining one Cy3-CTP-
labeled experimental target and Cy5-CTP-labeled reference target. Microarrays
were scanned on an Agilent DNA Microarray Scanner, using standard settings,
including automatic PMT adjustment.
Statistical analysis of microarrays
The data discussed in this publication have been deposited in NCBI Gene
Expression Omnibus (GEO; Barrett et al., 2007; http://www.ncbi.nlm.nih.gov/
geo/) and are accessible through GEO Series accession number GSE5914. The
data and analysis software is also available at the NIA ANOVA tool website
(Sharov et al., 2005b; http://lgsun.grc.nia.nih.gov/ANOVA/). Differential gene
expressions in various cell lines in the standard culture condition were analyzed
using the NIAArray Analysis software (Sharov et al., 2005b), which implements
ANOVA statistics with two additional methods to reduce the number of false
positives: (1) small error variances were replaced with the average error variance
estimated from 500 genes with similar signal intensity, and (2) false discovery
rates (FDR≤0.05) were used to select genes with differential expression, instead
of p-values (Benjamini and Hochberg, 1995). Mean center global adjustment
was used to remove differences between 2 batches of replications, which were
done with the same set of cell lines. Experiments without replication (LIF+,
LIF−, and RA+ experiments that were done simultaneously) were analyzed with
a 2-factor ANOVA (factorial design) with cell line (N=12) and treatment (N=3)as factors. The variance associated with interaction of factors was treated as error
variance. This analysis may be biased towards the increased stringency because
some interaction terms may be biologically relevant, but the stringency was not
compromised by these assumptions. Error variance adjustment and FDR
estimation were done as described above.
Principal component analysis (PCA) of log-transformed gene expression
levels was done using the SVD method within the NIA Array Analysis software
(Sharov et al., 2005b) based on averages for each cell line. Individual
replications were projected on the principal components and then ANOVAwas
used to estimate standard errors. Genes contributing to each principal
component were selected based on the following criteria: (1) significant
differential expressions between cell lines (FDR≤0.05), (2) high correlation
(abs(r)≥0.7), and (3) fold change in the direction of the principal component
(fold change N1.5). Because we wanted to separate the effects of cell lines from
those of culture conditions (LIF+, LIF−, and RA+), we carried out PCA for the
log expression of genes in the standard (LIF+) condition and for the centered log
expression obtained by subtracting cell line-specific average log expression in
all 3 culture conditions.
Signature genes for EGC and ECS lines and those for 129 and C57BL/6
strains were selected based on the ANOVA of grouped replications from all cell
lines in the standard LIF+ culture condition (FDR≤0.05) with additional
filtering based on: (1) significant differential expressions between all cell lines;
(2) fold change N1.5; and (3) the presence of proper gene symbols. Even if a
gene fell into both EGC–ESC and 129-C57BL/6 categories, it was included in
only one category with stronger effects. Genes that were differentially expressed
between EGC and ESC (or between 129 and C57BL/6) only in the RA+
condition were selected based on the following criteria: (1) differential
expressions in the RA+ condition was significant (FDR≤0.05, fold change
N1.5), and (2) the difference in ESC–EGC (or 129-C57BL/6) log ratios between
RA+ and LIF+ conditions was N1.76 (1.5-fold change).
Analysis of selected genes by gene ontology (GO) termswas carried out using
the hypergeometric distribution (FDR≤0.1) and enrichment ratio (N1.5) as
significance criteria with the NIA Mouse Gene Index (ver. mm7) software
(Sharov et al., 2005a). Only non-redundant genes with gene symbols were used
for analysis. BecausemanyGO categories are redundant (i.e., contain similar lists
of genes), we adjusted the calculation of FDR in the following manner. First, we
identified all redundant pairs of GO terms that had a correlation of gene presence
≥0.7. Second, in the list of GO terms ordered by increasing p-values, pi,
estimated from the hypergeometric distribution, GO term i was considered
redundant if it was redundant to at least one preceding term. Finally, the FDRwas:
FDRi ¼ pid Nni ;
where N is the total number of non-redundant GO terms, and ni is the number of
non-redundant GO terms from the start of the list until term i. This is a
modification of the standard equation for FDR (Benjamini and Hochberg, 1995).
Real-time quantitative RT-PCR
Primer sets for quantitative reverse transcriptase PCR (qRT-PCR; Supple-
mental Table S14) were designed and tested for SYBRGreen chemistry using an
established in-house protocol (Carter et al., 2003). Total RNA was used to
prepare cDNA as described previously (Carter et al., 2003). Because the
microarray targets were oligo(dT)-primed, all cDNA synthesis reactions were
oligo(dT)-primed as well, and qRT-PCR primer sets were designed so that PCR
amplicons were matched to the region upstream of microarray 60-mer oligo
probes when possible, or to the region within the 650 bp downstream. These
steps were taken to minimize possible bias due to the different locations of
amplicons and microarray oligos. Reactions were run on ABI 7900 HT
Sequence Detection Systems using the default cycling program, and data were
processed using SDS 2.2 software (Applied Biosystems).Acknowledgments
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